THIAZOLO[4,5-D]PYRIMIDINES - PART II - SYNTHESIS AND ANTI-HUMAN CYTOMEGALOVIRUS ACTIVITY IN-VITRO OF CERTAIN ACYCLONUCLEOSIDES AND ACYCLONUCLEOTIDES DERIVED FROM THE GUANINE ANALOG 5-AMINO-THIAZOLO[4,5-D]PYRIMIDINE-2,7(3H,6H)-DIONE
Gr. Revankar et al., THIAZOLO[4,5-D]PYRIMIDINES - PART II - SYNTHESIS AND ANTI-HUMAN CYTOMEGALOVIRUS ACTIVITY IN-VITRO OF CERTAIN ACYCLONUCLEOSIDES AND ACYCLONUCLEOTIDES DERIVED FROM THE GUANINE ANALOG 5-AMINO-THIAZOLO[4,5-D]PYRIMIDINE-2,7(3H,6H)-DIONE, Antiviral chemistry & chemotherapy, 9(1), 1998, pp. 53-63
The synthesis and in vitro antiviral activity of certain hydroxyalkoxy
methyl, hydroxyalkyl, hydroxyalkenyl and phosphonoalkenyl derivatives
of the guanine congener 5-aminothiazolo-[4,5-d]pyrimidine-2,7(3H,6H)-d
ione are reported. The compounds of this study were selected for their
structural similarity to acyclonucleosides with known anti-herpesviru
s activity. en-1-yl]thiazolo[4,5-d]pyrimidine-2,7(3H,6H)-dione was the
only member of the series to display significant in vitro activity ag
ainst human cytomegalovirus (HCMV); however, this compound did not inh
ibit other herpesviruses, human immunodeficiency virus type 1 or murin
e cytomegalovirus. It was found to have a cytotoxicity profile similar
to that of ganciclovir (DHPG). The antiviral effect was found to be s
ensitive to the initial viral input and the time of addition during th
e virus replication cycle. Significantly, the compound was found to ha
ve equal anti-HCMV activity, against standard virus strains, to DHPC,
but also showed potent activity against DHPG-resistant virus strains,
except for a strain mutated in the UL97 (phosphotransferase) gene.